RCEL
Avita Medical Ltd
NASDAQ: RCEL · HEALTHCARE · MEDICAL DEVICES
$4.32
+2.13% today
Updated 2026-04-30
Market cap
$133.26M
P/E ratio
—
P/S ratio
1.86x
EPS (TTM)
$-1.74
Dividend yield
—
52W range
$3 – $10
Volume
0.2M
Avita Medical Ltd (RCEL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-67.80%
Operating margin
-59.10%
ROE
-1,746.00%
ROA
-39.10%
Debt/equity
-0.13x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $790993.00 | $-12.78M | -42.69% | -574.37% | -1,615.42% |
| 2007 | $1.20M | $-11.66M | 59.10% | -362.86% | -968.80% |
| 2008 | $2.37M | $-4.14M | 65.18% | -171.55% | -174.86% |
| 2009 | $2.30M | $-5.01M | 70.85% | -113.00% | -217.95% |
| 2010 | $3.34M | $-2.09M | 70.84% | -131.31% | -62.54% |
| 2011 | $3.35M | $-7.59M | 71.58% | -184.73% | -226.42% |
| 2012 | $2.81M | $-8.09M | 75.97% | -306.69% | -287.49% |
| 2013 | $2.68M | $-5.15M | 75.00% | -254.16% | -191.84% |
| 2014 | $985647.00 | $-7.87M | 70.66% | -887.04% | -798.10% |
| 2015 | $1.00M | $-10.27M | 59.92% | -1,133.14% | -1,025.14% |
| 2016 | $1.18M | $-11.51M | 57.17% | -1,073.17% | -974.99% |
| 2017 | $1.26M | $-17.21M | 41.23% | -1,489.88% | -1,370.83% |
| 2019 | $5.40M | $-24.62M | 77.97% | -458.15% | -456.31% |
| 2020 | $5.40M | $-24.62M | 77.97% | -458.15% | -456.31% |
| 2021 | $33.02M | $-25.14M | 81.52% | -76.06% | -76.13% |
| 2022 | — | — | — | — | — |
| 2022 | $34.42M | $-26.66M | 82.45% | -79.91% | -77.47% |
| 2023 | $50.14M | $-35.38M | 84.48% | -85.07% | -70.56% |
| 2024 | $64.25M | $-61.84M | 85.85% | -88.08% | -96.26% |
| 2025 | $71.61M | $-48.59M | 82.13% | -58.56% | -67.85% |